An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

Ghislaine A. van Mastrigt*, Silvia M. Evers, Marco Heerings, Leo H. Visser, Rob P. Ruimschotel, Astrid Hussaarts, Lotte Duyverman, Joyce Valkenburg-Vissers, Job Cornelissen, Michel Bos, Maarten van Droffelaar, Peter J. Jongen

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original languageEnglish
Article number0236-RT.R1/1609300
Pages (from-to)967-980
Number of pages14
JournalJournal of Medical Economics
Volume22
Issue number10
DOIs
Publication statusPublished - 3 Oct 2019

Keywords

  • Relapsing remitting
  • multiple sclerosis
  • trial-based
  • economic evaluation
  • intense social cognitive theory-based treatment
  • self-efficacy
  • multidisciplinary
  • QUALITY-OF-LIFE
  • PREFERENCE-BASED MEASURE
  • SELF-EFFICACY
  • COST-EFFECTIVENESS
  • PHYSICAL-ACTIVITY
  • BEHAVIORAL THERAPY
  • UTILITY MEASURES
  • ADJUSTMENT GROUP
  • CLINICAL-TRIAL
  • HEALTH

Cite this

van Mastrigt, Ghislaine A. ; Evers, Silvia M. ; Heerings, Marco ; Visser, Leo H. ; Ruimschotel, Rob P. ; Hussaarts, Astrid ; Duyverman, Lotte ; Valkenburg-Vissers, Joyce ; Cornelissen, Job ; Bos, Michel ; van Droffelaar, Maarten ; Jongen, Peter J. / An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability. In: Journal of Medical Economics. 2019 ; Vol. 22, No. 10. pp. 967-980.
@article{c26715d8ff1948bc947fc289543156e7,
title = "An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability",
keywords = "Relapsing remitting, multiple sclerosis, trial-based, economic evaluation, intense social cognitive theory-based treatment, self-efficacy, multidisciplinary, QUALITY-OF-LIFE, PREFERENCE-BASED MEASURE, SELF-EFFICACY, COST-EFFECTIVENESS, PHYSICAL-ACTIVITY, BEHAVIORAL THERAPY, UTILITY MEASURES, ADJUSTMENT GROUP, CLINICAL-TRIAL, HEALTH",
author = "{van Mastrigt}, {Ghislaine A.} and Evers, {Silvia M.} and Marco Heerings and Visser, {Leo H.} and Ruimschotel, {Rob P.} and Astrid Hussaarts and Lotte Duyverman and Joyce Valkenburg-Vissers and Job Cornelissen and Michel Bos and {van Droffelaar}, Maarten and Jongen, {Peter J.}",
year = "2019",
month = "10",
day = "3",
doi = "10.1080/13696998.2019.1609300",
language = "English",
volume = "22",
pages = "967--980",
journal = "Journal of Medical Economics",
issn = "1369-6998",
publisher = "Routledge/Taylor & Francis Group",
number = "10",

}

van Mastrigt, GA, Evers, SM, Heerings, M, Visser, LH, Ruimschotel, RP, Hussaarts, A, Duyverman, L, Valkenburg-Vissers, J, Cornelissen, J, Bos, M, van Droffelaar, M & Jongen, PJ 2019, 'An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability', Journal of Medical Economics, vol. 22, no. 10, 0236-RT.R1/1609300, pp. 967-980. https://doi.org/10.1080/13696998.2019.1609300

An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability. / van Mastrigt, Ghislaine A.; Evers, Silvia M.; Heerings, Marco; Visser, Leo H.; Ruimschotel, Rob P.; Hussaarts, Astrid; Duyverman, Lotte; Valkenburg-Vissers, Joyce; Cornelissen, Job; Bos, Michel; van Droffelaar, Maarten; Jongen, Peter J.

In: Journal of Medical Economics, Vol. 22, No. 10, 0236-RT.R1/1609300, 03.10.2019, p. 967-980.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

AU - van Mastrigt, Ghislaine A.

AU - Evers, Silvia M.

AU - Heerings, Marco

AU - Visser, Leo H.

AU - Ruimschotel, Rob P.

AU - Hussaarts, Astrid

AU - Duyverman, Lotte

AU - Valkenburg-Vissers, Joyce

AU - Cornelissen, Job

AU - Bos, Michel

AU - van Droffelaar, Maarten

AU - Jongen, Peter J.

PY - 2019/10/3

Y1 - 2019/10/3

KW - Relapsing remitting

KW - multiple sclerosis

KW - trial-based

KW - economic evaluation

KW - intense social cognitive theory-based treatment

KW - self-efficacy

KW - multidisciplinary

KW - QUALITY-OF-LIFE

KW - PREFERENCE-BASED MEASURE

KW - SELF-EFFICACY

KW - COST-EFFECTIVENESS

KW - PHYSICAL-ACTIVITY

KW - BEHAVIORAL THERAPY

KW - UTILITY MEASURES

KW - ADJUSTMENT GROUP

KW - CLINICAL-TRIAL

KW - HEALTH

U2 - 10.1080/13696998.2019.1609300

DO - 10.1080/13696998.2019.1609300

M3 - Article

VL - 22

SP - 967

EP - 980

JO - Journal of Medical Economics

JF - Journal of Medical Economics

SN - 1369-6998

IS - 10

M1 - 0236-RT.R1/1609300

ER -

van Mastrigt GA, Evers SM, Heerings M, Visser LH, Ruimschotel RP, Hussaarts A et al. An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability. Journal of Medical Economics. 2019 Oct 3;22(10):967-980. 0236-RT.R1/1609300. https://doi.org/10.1080/13696998.2019.1609300

Access to Document